MedPath
NMPA Approval

Atomoxetine Hydrochloride Oral Solution

国药准字HJ20180057

LILLY SA

October 17, 2023

H20180057

Drug Information

盐酸托莫西汀口服溶液

择思达

口服溶液剂

100ml:400mg,4mg/mL(按C₁₇H₂₁NO计)

化学药品

October 17, 2023

May 15, 2028

Company Information

Applicant Company

LILLY SA

Avda.de la Industria,30 28108 Alcobendas (Madrid) Spain

Manufacturing Company

PATHEON FRANCE

40 Boulevard De Champaret, Bourgoin-Jallieu, F-38300, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸托莫西汀口服溶液 - NMPA 批准文号 | MedPath